AI Driven Diagnostics Capitalize on Bayer Diagnostics AI focus by offering AI powered diagnostic analytics and clinical decision support that integrate with Microsoft Azure and .NET workflows; propose co development of ML models for assay data interpretation and visualization dashboards to speed research and improve accuracy.

Cloud and Data Align with Bayer's cloud footprint by delivering cloud native platforms, secure data lakes, and data governance for lab and product data using Azure; emphasize scalable analytics, interoperability, and security controls such as HSTS.

Strategic Partnerships Leverage existing relationships with Deloitte and ThoughtWorks to propose joint go to market programs for AI driven drug discovery, diagnostics software, and digital transformation across R&D and manufacturing operations; offer flexible engagement models and ready made accelerators.

Manufacturing Expansion Bayer's global manufacturing expansion signals a focus on resilient operations; present digital manufacturing solutions including MES, predictive maintenance, IoT monitoring, and digital twin workflows to improve uptime, yield, and traceability in equipment and components supply.

Regulatory Readiness With leadership changes and competitive dynamics in the life sciences space, provide regulatory aligned quality management, LIMS integration, traceability, and contract and vendor risk management to safeguard compliance and speed time to market for new diagnostics products.